# Colostrum extracellular vesicles are neuroprotective in models of Parkinson's disease

**Authors:** Dawson Hollingsworth, Shefali Srivastava, Samia Akter, Mohit Kumar, Soumya Sagar Dey, Sudipta Panja, Xiaoqing Du, Arnab Saha, Pravin Yeapuri, Shaurav Bhattarai, Emma G. Foster, Rana Kadry, Nada Fayez, Davina Oludipe, Emma Ehrenkranz, R Lee Mosley, John Oehlerking, Keith Swarts, Guoku Hu, Howard E. Gendelman, Susmita Sil

PMC · DOI: 10.7150/thno.128257 · Theranostics · 2026-01-22

## TL;DR

Colostrum extracellular vesicles protect brain cells in a mouse model of Parkinson's disease by reducing inflammation and supporting neuron health.

## Contribution

This study demonstrates that colostrum extracellular vesicles have neuroprotective effects in Parkinson's disease models through immune regulation.

## Key findings

- C-EVs reduced microglial activation and restored neuronal responses in MPTP-intoxicated mice.
- C-EVs controlled pro-inflammatory cytokines and chemokines in disease-affected brain regions.
- C-EVs loaded with specific miRNAs attenuated inflammation in activated microglia.

## Abstract

Rationale: Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects movement, muscle control, and balance. Effective therapeutic options for this condition are limited. Natural therapies, including lifestyle changes, probiotics, and muscle relaxants, have received attention for symptomatic relief. Colostrum, particularly its extracellular vesicles (C-EVs), has emerged as a promising nutraceutical with the potential to improve therapeutic outcomes in divergent diseases.

Methods: We purified and characterized (C-EVs) as a putative cell-based therapy. Theranostic (biodistribution, diagnostic, and therapeutic) efficacy studies were performed in C-EV-treated mice intoxicated with methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The C-EV tissue distribution, anti-inflammatory and neurorestorative activities were examined. These include transcriptomic, immune, and neuroprotective profiles linked to disease outcomes.

Results: C-EV-treated MPTP mice showed reduced microglial activation and restored neuronal responses. RNA sequencing and transcriptomic analyses have demonstrated reduced immune cell recruitment and activation in the disease-affected brain subregions. The activation of canonical inflammasomes, pro-inflammatory cytokines, and chemokine expression was controlled. C-EV treatment reduced the levels of disease-associated immune-regulatory transcription factors. Simultaneously, Treg-associated adaptive immune responses increased. Multiple C-EV-miR-isolated immune regulatory cargos are linked to neuroinflammation and nigral preservation. C-EVs loaded with miR-20a-5p, miR-23b-3p, let-7a-5p, miR-22-3p, and miR-30a-3p mimics attenuated pro-inflammatory cytokines in activated microglia.

Conclusions: C-EVs elicit neuroprotective responses in MPTP-intoxicated mice. These responses control microglial activation and facilitate neuroprotective responses.

## Linked entities

- **Diseases:** Parkinson's disease (MONDO:0005180)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mir223 (microRNA 223) [NCBI Gene 723814] {aka Mirn223, miR-223, mmu-mir-223}
- **Diseases:** neuroinflammation (MESH:D000090862), neurodegenerative disorder (MESH:D019636), inflammatory (MESH:D007249), PD (MESH:D010300)
- **Chemicals:** C-EV (MESH:C074207), MPTP (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12905751/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12905751/full.md

## References

199 references — full list in the complete paper: https://tomesphere.com/paper/PMC12905751/full.md

---
Source: https://tomesphere.com/paper/PMC12905751